Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Clinical trial NCT06451770 · RECRUITING
Trial details
- NCT number
- NCT06451770
- Sponsor
- Verve Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.